GB0719544D0 - Cocoa extract and use thereof - Google Patents

Cocoa extract and use thereof

Info

Publication number
GB0719544D0
GB0719544D0 GBGB0719544.9A GB0719544A GB0719544D0 GB 0719544 D0 GB0719544 D0 GB 0719544D0 GB 0719544 A GB0719544 A GB 0719544A GB 0719544 D0 GB0719544 D0 GB 0719544D0
Authority
GB
United Kingdom
Prior art keywords
cocoa extract
cocoa
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0719544.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Barry Callebaut AG
Original Assignee
Barry Callebaut AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Barry Callebaut AG filed Critical Barry Callebaut AG
Priority to GBGB0719544.9A priority Critical patent/GB0719544D0/en
Publication of GB0719544D0 publication Critical patent/GB0719544D0/en
Priority to JP2010504545A priority patent/JP5432122B2/ja
Priority to PCT/EP2008/003323 priority patent/WO2008131911A1/en
Priority to EP08749114A priority patent/EP2142203A1/en
Priority to US12/597,550 priority patent/US8597692B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A61K36/5777—Theobroma, e.g. cocao or cocoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Addiction (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Psychiatry (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Pain & Pain Management (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Anesthesiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
GBGB0719544.9A 2007-04-26 2007-10-08 Cocoa extract and use thereof Ceased GB0719544D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0719544.9A GB0719544D0 (en) 2007-10-08 2007-10-08 Cocoa extract and use thereof
JP2010504545A JP5432122B2 (ja) 2007-04-26 2008-04-24 カカオ抽出物の使用
PCT/EP2008/003323 WO2008131911A1 (en) 2007-04-26 2008-04-24 Cocoa extract and use thereof
EP08749114A EP2142203A1 (en) 2007-04-26 2008-04-24 Cocoa extract and use thereof
US12/597,550 US8597692B2 (en) 2007-04-26 2008-04-24 Cocoa extract and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0719544.9A GB0719544D0 (en) 2007-10-08 2007-10-08 Cocoa extract and use thereof

Publications (1)

Publication Number Publication Date
GB0719544D0 true GB0719544D0 (en) 2007-11-14

Family

ID=38739241

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0719544.9A Ceased GB0719544D0 (en) 2007-04-26 2007-10-08 Cocoa extract and use thereof

Country Status (5)

Country Link
US (1) US8597692B2 (enExample)
EP (1) EP2142203A1 (enExample)
JP (1) JP5432122B2 (enExample)
GB (1) GB0719544D0 (enExample)
WO (1) WO2008131911A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8609174B2 (en) * 2006-11-17 2013-12-17 Barry Callebaut Ag Method for producing a soluble cocoa product from cocoa powder
WO2008059064A1 (en) 2006-11-17 2008-05-22 Barry Callebaut Ag Method for producing a soluble cocoa product from cocoa powder
GB0719542D0 (en) * 2007-10-08 2007-11-14 Barry Callebaut Ag Use of cocoa extract
GB0719545D0 (en) * 2007-10-08 2007-11-14 Barry Callebaut Ag Novel use of cocoa extract
GB0719543D0 (en) 2007-10-08 2007-11-14 Barry Callebaut Ag Cocoa extract and novel use thereof
GB0724716D0 (en) * 2007-12-19 2008-01-30 Barry Callebaut Ag Process
WO2010114567A1 (en) 2009-04-03 2010-10-07 Dianaplantsciences, Inc. Production and extraction of procyanidins from plant cell cultures
JP2013538590A (ja) * 2010-10-04 2013-10-17 ダイアナプラントサイエンシズ エス．アー．エス． 植物の細胞培養物由来のプロシアニジンの生産及び抽出
US20140087054A1 (en) * 2011-03-24 2014-03-27 Meiji Co., Ltd. Coffee beverage and process for producing same
ITTV20120064A1 (it) * 2012-04-19 2013-10-20 R I Group Srl Estratto per trattamento delle cefalee primitive
EP2934561B1 (en) * 2012-12-20 2022-08-10 Arabian German Medical Products Co. W.L.L. Composition comprising raphanus, theobroma and passiflora for treating opioid and alcohol abuse
ES2552706B1 (es) * 2014-05-29 2016-09-13 Universitat De Les Illes Balears La teobromina y sus derivados para el tratamiento o prevenciónde la litiasis renal
CN104223353B (zh) * 2014-08-19 2016-02-24 云南中烟工业有限责任公司 一种烟草发酵所得烟用香料及其应用
CN104232689A (zh) * 2014-09-30 2014-12-24 云南中烟工业有限责任公司 一种百合与烟草混合发酵制备的烟用香料及其应用
WO2023164338A2 (en) * 2022-02-23 2023-08-31 The Jonathan Hurt Living Trust Compositions and methods for the treatment of sexual dysfunctions

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU76148A1 (enExample) 1976-11-08 1978-07-10
DE3908649A1 (de) 1989-03-16 1990-09-20 Jacobs Suchard Ag Verfahren zur herstellung eines loeslichen kakaoerzeugnisses
FR2669537B1 (fr) 1990-11-28 1993-02-19 Oreal Composition amincissante a base d'alpha-2-bloqueurs.
DE69331843T2 (de) 1992-07-08 2002-09-26 Kyowa Hakko Kogyo Co., Ltd. Xanthine-Derivate als Antidepressiva
FR2708198B1 (fr) 1993-07-28 1995-10-20 Dior Christian Parfums Composition cosmétique ou pharmaceutique, notamment dermatologique contenant un extrait de Tephrosia, en particulier Tephrosia purpurea.
US5554645A (en) 1994-10-03 1996-09-10 Mars, Incorporated Antineoplastic cocoa extracts and methods for making and using the same
CN1037315C (zh) 1995-03-24 1998-02-11 秦国忠 咖啡健神饮料
ES2230573T3 (es) 1995-12-26 2005-05-01 Suntory Limited Agente anti-obesidad cuyo principio activo es la procianidina.
US6391310B1 (en) 1996-03-13 2002-05-21 Archer Daniels Midland Company Method of preparing and using isoflavones for the treatment of neurological symptoms
US6297273B1 (en) 1996-04-02 2001-10-02 Mars, Inc. Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions
CA2260892A1 (en) 1996-07-17 1998-01-22 Nicada, Inc. Appetite suppression
US5667793A (en) 1996-08-02 1997-09-16 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin care compositions for treating cellulite
US6015913A (en) 1996-09-06 2000-01-18 Mars, Incorporated Method for producing fat and/or solids from cocoa beans
FR2754709B1 (fr) 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
US20050245612A1 (en) 2004-05-03 2005-11-03 Blass John P Pharmaceutical compositions for metabolic insufficiencies
WO1999034675A1 (en) 1998-01-07 1999-07-15 Nutracorp Scientific, Inc. Promoting mobilization and catabolism of lipids
EP1106073B1 (en) 1998-06-18 2008-08-20 Meiji Seika Kaisha, Ltd. Cocoa powder rich in polyphenols, process for producing the same and modified cocoa containing the same
US20030206981A1 (en) 1999-04-15 2003-11-06 Lotte Confectionery Co., Ltd. Methods of using and compositions comprising cacao extract including dietary fiber
US6174542B1 (en) 1999-07-01 2001-01-16 Pms Mood Food, Inc. Dietary supplements and food products for treating symptoms of PMS
US20010041675A1 (en) 2000-01-24 2001-11-15 Jacobs Robert H. Satisfy composition and method of weight control
MXPA02008819A (es) 2000-03-10 2003-02-12 Yakult Honsha Kk Inhibidor de actividad de alfa amilasa.
FR2810242B1 (fr) 2000-06-16 2003-01-17 Nuxe Lab Composition cosmetique et/ou dermatologique a base d'extraits de cacao
FR2812873B1 (fr) 2000-08-11 2003-08-01 Barry Callebaut France Procede de production de polyphenols a partir de feves de cacao
JP2002173435A (ja) 2000-09-26 2002-06-21 Ryuei Soken:Kk 抗肥満剤および当該抗肥満剤の投与方法
AR033593A1 (es) 2000-11-21 2003-12-26 Nestle Sa Una albumina de cacao recientemente identificada y su utilizacion en la produccion de sabor a cacao y chocolate
US6420350B1 (en) 2001-01-18 2002-07-16 Goen Group, Inc. Weight loss product
US20020172732A1 (en) * 2001-03-21 2002-11-21 Wies Ter Laak Composition comprising cocoa
JP2002272376A (ja) * 2001-03-21 2002-09-24 Yuji Dokin チョコレート等の食料品
US20020192308A1 (en) 2001-06-14 2002-12-19 John Mamana Method and composition for controlling weight
US7514107B2 (en) 2002-03-21 2009-04-07 Mars, Incorporated Treatment of diseases involving defective gap junctional communication
ATE387098T1 (de) 2002-05-29 2008-03-15 Sugar Company S P A In Forma A Nahrungsmittelzusammensetzungen auf der basis von mit intensivsüssstoff vermischtem kakao und deren herstellungsverfahren
KR100531472B1 (ko) 2002-08-09 2005-11-28 주식회사 이롬 항산화 활성을 가지는 찔레나무 추출물을 포함하는 화장품 조성물 및 상기 추출물의 제조방법
US7585523B2 (en) 2002-08-27 2009-09-08 Targeted Medical Pharma Composition and method to augment and sustain neurotransmitter production
US20050037025A1 (en) 2002-10-03 2005-02-17 Gow Robert T. Methods and compositions comprising kava and mate' or theobromine
WO2004082609A2 (en) 2003-03-14 2004-09-30 Pro-Health, Inc. Composition and method for appetite and carving suppression and mood enhancement
DE10315025A1 (de) 2003-04-02 2004-10-14 Bioplanta Arzneimittel Gmbh Wirkstoffkombination von ω3-fettsäurehaltigen Ölen mit polyphenolhaltigen Pflanzenextrakten und deren Verwendung
US20050181083A1 (en) 2003-04-18 2005-08-18 Toyo Shinyaku Co., Ltd. Diet food product
US20070043109A1 (en) 2003-05-20 2007-02-22 Sederma Sas Slimming cosmetic composition
CA2554071C (en) 2004-01-28 2013-05-07 Mars, Incorporated A-type procyanidins useful in the treatment of nitric oxide mediated disorders
KR100795327B1 (ko) 2004-02-10 2008-01-21 아사히비루 가부시키가이샤 근장력 증강제
US20050277657A1 (en) 2004-06-15 2005-12-15 Dusan Ninkov Method of protection of biologically active essential oils and pharmaceutical composition for weight control and enhance fat burning in adults, adolescents and children
WO2006017157A1 (en) 2004-07-09 2006-02-16 Pure World Botanicals, Inc. Weight loss composition
FR2879448B1 (fr) 2004-12-17 2007-01-26 Oreal Composition amincissante comprenant une base xanthique, un dimethicone copolyol et une poudre de polyurethane
US20060134230A1 (en) 2004-12-17 2006-06-22 Sal Abraham Weight loss composition and formulation
US20060182825A1 (en) 2005-02-11 2006-08-17 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods and compounds for the treatment of obesity and obesity-related disorders
US20060204599A1 (en) 2005-03-14 2006-09-14 Wheat Jared R Dietary supplement and method of using same
US20060210653A1 (en) 2005-03-18 2006-09-21 Gardiner Paul T Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition
FR2885050B1 (fr) 2005-04-29 2008-09-05 Nuxe Sa Lab Composition amincissante a base d'extraits de cacao.
FR2885299B1 (fr) 2005-05-03 2009-11-20 Nuxe Lab Utilisation de polyphenols de cacao pour reguler la pigmentation de la peau
FR2885297B1 (fr) 2005-05-04 2007-07-20 Nuxe Sa Lab Nouvelle utilisation de polyphenols de cacao pour la regulation de cycle cellulaire.
JP5775656B2 (ja) 2005-06-03 2015-09-09 ホリズン サイエンス ピーティーワイ リミテッド ボディマス再分布性を有する物質
CA2550272A1 (en) 2005-06-17 2006-12-17 Smartburn Formulations Ltd. Diet supplement for causing rapid weight loss, controlling appetite, managing stress, supporting relaxation, combating fatigue and supporting mental well-being
WO2007002851A2 (en) * 2005-06-29 2007-01-04 Mars, Incorporated Thermally-processed cocoa products useful for vascular health improvement
GB0520917D0 (en) 2005-10-14 2005-11-23 Zumbe Albert Chocolate based appetite suppressant
US20070104805A1 (en) 2005-11-01 2007-05-10 Udell Ronald G Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives
US8945652B2 (en) 2005-11-23 2015-02-03 The Coca-Cola Company High-potency sweetener for weight management and compositions sweetened therewith
EP1845798A1 (en) 2005-12-02 2007-10-24 Amedei S.R.L. Foofstuff based on cocoa and dehydrated fruit
JP2009521475A (ja) 2005-12-23 2009-06-04 マース インコーポレーテッド 皮膚の保護および改善
WO2007082703A1 (en) 2006-01-17 2007-07-26 Barry Callebaut Ag Use of cacao polyphenols in beer production
US20070178176A1 (en) 2006-02-02 2007-08-02 Chithan Kandaswami Composition and method for promoting weight loss
CA2659099A1 (en) * 2006-06-15 2007-12-21 Mars, Incorporated Use of cocoa flavanols and procyanidins to improve executive cognitive and cerebral blood flow
FR2904773B1 (fr) 2006-08-11 2008-11-07 Lvmh Rech Composition cosmetique amincissante contenant un extrait de biomasse de l'algue neochloris oleoabundans
GB0719545D0 (en) 2007-10-08 2007-11-14 Barry Callebaut Ag Novel use of cocoa extract
GB0719542D0 (en) 2007-10-08 2007-11-14 Barry Callebaut Ag Use of cocoa extract

Also Published As

Publication number Publication date
JP5432122B2 (ja) 2014-03-05
US20100189829A1 (en) 2010-07-29
US8597692B2 (en) 2013-12-03
JP2010526036A (ja) 2010-07-29
EP2142203A1 (en) 2010-01-13
WO2008131911A1 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
GB0719544D0 (en) Cocoa extract and use thereof
GB0719542D0 (en) Use of cocoa extract
IL205571A0 (en) 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin
EP2185692A4 (en) HCO32 AND HCO27 AND RELATED EXAMPLES
ZA201001300B (en) Antigen-asjuvant compositions and methods
ZA201004239B (en) 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof
ZA200810323B (en) Fkbp-l and uses thereof
LT2064327T (lt) Dbait ir jų panaudojimas
GB0719545D0 (en) Novel use of cocoa extract
ZA201106702B (en) Sceletium extract and uses thereof
EP2095718A4 (en) TEA EXTRACT
GB2464645B (en) Quercetin-3'-O-phosphate and its uses
EP2150233A4 (en) ANTIMICROBIAL AND ANTI-INFLAMMATORY ISOLATES OF LICORSE EXTRACT
GB0721291D0 (en) Methods and compositions
ZA200903906B (en) Carboranylporphyrins and uses thereof
IL202440A0 (en) Plant extract and its therapeutic use
ZA200905427B (en) Rasp and cover
EP2077262A4 (en) IMINOPYRIDINE DERIVATIVE AND USE THEREOF
IL199991A0 (en) Soluble fcgammaria and related methods
GB0719526D0 (en) Compositions and methods
IL209220A0 (en) Plant extract and its therapeutic use
GB0719543D0 (en) Cocoa extract and novel use thereof
ZA201000357B (en) 2-Azetidinemethaneamines and 2-pyrrolidinemethaneamines as Taar-Ligands
GB0707069D0 (en) Methods and uses
EP2168951A4 (en) AZOLYLMETHYLIDENHYDRAZINE DERIVATIVE AND ITS USE

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)